Enache, Oana M.
Rendo, Veronica http://orcid.org/0000-0002-2983-4020
Abdusamad, Mai
Lam, Daniel
Davison, Desiree
Pal, Sangita
Currimjee, Naomi
Hess, Julian
Pantel, Sasha
Nag, Anwesha
Thorner, Aaron R.
Doench, John G. http://orcid.org/0000-0002-3707-9889
Vazquez, Francisca
Beroukhim, Rameen http://orcid.org/0000-0001-6303-3609
Golub, Todd R. http://orcid.org/0000-0003-0113-2403
Ben-David, Uri http://orcid.org/0000-0001-7098-2378
Article History
Received: 7 September 2019
Accepted: 3 April 2020
First Online: 18 May 2020
Change Date: 25 June 2020
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41588-020-0663-9
Competing interests
: J.G.D. consults for Tango Therapeutics, Foghorn Therapeutics, and Pfizer. T.R.G. is a paid advisor to GlaxoSmithKline and Sherlock Biosciences. R.B. owns shares in Ampressa and receives grant funding from Novartis. D.D. is an employee of Cellarity.